MoneyWorks4Me

Panacea Biotec - Quaterly Results

14 Feb 2023 Evaluate
The topline surged 87.03% to Rs. 719.70 millions for the December 2022 quarter as against Rs. 384.80 millions during the corresponding quarter last year.The Total Profit for the quarter ended December 2022 of Rs. 132.40 millions grew from Rs.-224.30 millions Operating profit Margin for the quarter ended December 2022 improved to 220.00% as compared to -140.60% of corresponding quarter ended December 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 719.70 384.80 87.03 1820.50 1940.00 -6.16 2355.00 3435.60 -31.45
Other Income 97.10 23.80 307.98 241.60 100.00 141.60 125.70 207.40 -39.39
PBIDT 220.00 -140.60 -256.47 -418.90 -433.00 -3.26 -601.10 212.40 -383.00
Interest 26.80 19.10 40.31 73.60 56.00 31.43 70.40 75.20 -6.38
PBDT 193.20 -159.70 -220.98 -492.50 -489.00 0.72 -671.50 137.20 -589.43
Depreciation 60.80 64.60 -5.88 186.00 193.70 -3.98 264.30 265.70 -0.53
PBT 132.40 -224.30 -159.03 -678.50 -682.70 -0.62 -935.80 -128.50 628.25
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.60 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -7.10 0.00
PAT 132.40 -224.30 -159.03 -678.50 -682.70 -0.62 -935.80 -144.10 549.41
Equity 61.30 61.30 0.00 61.30 61.30 0.00 61.30 61.30 0.00
PBIDTM(%) 30.57 -36.54 -183.66 -23.01 -22.32 3.09 -25.52 6.18 -512.86
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..